Publicaciones (228) Publicaciones de José Luis Labandeira García Ver datos de investigación referenciados.

filter_list

2025

  1. DICER1-Related Pediatric Thyroid Neoplasm with Follicular and Morular Growth: A Tumor that Did Not Read the Textbook

    Endocrine Pathology, Vol. 36, Núm. 1

  2. Defective Olfactomedin-2 connects adipocyte dysfunction to obesity

    Nature Communications , Vol. 16, Núm. 1

  3. Delivery of monoclonal antibodies to the brain: the impact of nanocarrier structure

    Drug Delivery and Translational Research

  4. Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms

    Neurotherapeutics, Vol. 22, Núm. 2

  5. Involvement of Neuroinflammation and Oxidative Stress in L-DOPA-Induced Dyskinesia in Parkinson’s Disease: Role of Renin–Angiotensin System and ROCK Pathway

    Antioxidants, Vol. 14, Núm. 10

  6. JNK1 in SF1 neurons regulates the central action of thyroid hormones on hepatic lipid metabolism

    Molecular Metabolism, Vol. 98

  7. Plasma small extracellular vesicles: Markers and mediators of atrial scar, in patients with atrial fibrillation

    Heart Rhythm

  8. Renin-angiotensin system as an emerging target to modulate adult neurogenesis in health and disease

    Stem Cell Research and Therapy , Vol. 16, Núm. 1

  9. Renin–Angiotensin System Autoantibody Network in Parkinson’s Disease Patients

    Antioxidants, Vol. 14, Núm. 6

2024

  1. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons

    Frontiers in Immunology, Vol. 15

  3. Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons

    npj Parkinson's Disease, Vol. 10, Núm. 1

  4. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

    Molecular Metabolism, Vol. 79

  5. Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain

    Neuropathology and Applied Neurobiology, Vol. 50, Núm. 1

  6. Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity

    Journal of Controlled Release, Vol. 372, pp. 295-303

  7. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models

    Stem Cell Research and Therapy, Vol. 15, Núm. 1

  8. The role of the brain renin-angiotensin system in Parkinson´s disease

    Translational Neurodegeneration, Vol. 13, Núm. 1

2023

  1. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 110

  2. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

    Brain, Behavior, and Immunity, Vol. 108, pp. 255-268

  3. Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner

    Nature Communications, Vol. 14, Núm. 1